Navigation Links
MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
Date:10/7/2009

opedic devices will provide MedShape with a distinctive advantage in the marketplace," stated Chris Fair, MedShape's Chief Operating Officer.

Mr. Leach brings over 25 years of sales and marketing experience in orthopedics as well as a background in international markets. "Rick's diverse experience in sales, marketing and international markets will be instrumental as we launch products both in the U.S. and abroad. We are honored to have him join us," stated Fair.

MedShape Solutions recently introduced the Morphix(TM) Suture Anchor system in select markets across the U.S. The Morphix(TM) anchor is the only orthopedic device currently available that utilizes PEEK Altera(TM), a proprietary shape memory PEEK material.

About MedShape Solutions, Inc.:

MedShape Solutions, Inc. is a privately held medical device company based in Atlanta, GA. MedShape Solutions, Inc. is committed to creating and delivering unique shape memory based technologies in the field of orthopedics and to Shaping the Future of Orthopedics(TM). More information can be found at www.medshape.com

Contact: Chris Fair, Chief Operating Officer, 404-249-9155, chris.fair@medshape.com

SOURCE MedShape Solutions, Inc.


'/>"/>
SOURCE MedShape Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
2. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
3. Quark Pharmaceuticals Appoints New Chief Medical Officer
4. West Pharmaceutical Services, Inc. Appoints New Director
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Curemark Appoints Preeminent Pediatrics Gastroenterologist
7. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
10. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
11. NovaRx Appoints Industry Veteran as President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Illness often undiscovered and undertreated among the uninsured 3A Harvard study 59784 1Illness often undiscovered and undertreated among the uninsured 3A Harvard study 59784 2FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 1FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 2FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 3FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 4Checkered history of mother and daughter cells explains cell cycle differences 10424 1Checkered history of mother and daughter cells explains cell cycle differences 10424 2Checkered history of mother and daughter cells explains cell cycle differences 10424 3